SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure
April 30, 2024 08:30 ET
|
SeaStar Medical Holding Corporation
DENVER, April 30, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of...
In Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of Antimicrobial Agents and Chemotherapy
April 30, 2024 08:00 ET
|
Matinas BioPharma Holdings, Inc.
BEDMINSTER, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies...
AACOM Releases Historic Statement After “Food As Medicine” Special Session
April 19, 2024 13:41 ET
|
American Association of Colleges of Osteopathic Medicine
Kansas City, MO, April 19, 2024 (GLOBE NEWSWIRE) -- Today, the American Association of Colleges of Osteopathic Medicine (AACOM) convened a special Friday Forum during it’s Educating Leaders 2024...
Private Bancorp of America, Inc. Announces Strong Net Income and Earnings Per Share for First Quarter 2024
April 19, 2024 05:00 ET
|
Private Bancorp of America, Inc.
First Quarter 2024 Highlights Net income for the first quarter of 2024 of $7.9 million, compared to $7.9 million in the prior quarter and $9.0 million in the first quarter of 2023. Net income for...
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
April 17, 2024 16:00 ET
|
SeaStar Medical Holding Corporation
DENVER, April 17, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a commercial-stage medical device company developing proprietary...
AACOM Recognizes Award-Winning Leaders and Students at Annual Conference
April 17, 2024 08:35 ET
|
American Association of Colleges of Osteopathic Medicine
Bethesda, MD, April 17, 2024 (GLOBE NEWSWIRE) -- Today, the American Association of Colleges of Osteopathic Medicine (AACOM) is proud to honor four outstanding individuals during its sold-out annual...
SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference
April 11, 2024 08:30 ET
|
SeaStar Medical Holding Corporation
DENVER, April 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
March 27, 2024 16:05 ET
|
Matinas BioPharma Holdings, Inc.
Clear registration pathway and FDA agreement on the ORALTO Phase 3 trial for MAT2203 represent critical steps forward and supports partnership discussions Continued success of Compassionate/Expanded...
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
March 27, 2024 08:30 ET
|
SeaStar Medical Holding Corporation
Restatement of non-cash items is not expected to materially impact cash position or operations DENVER, March 27, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a...
Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical Response
March 22, 2024 09:15 ET
|
Matinas BioPharma Holdings, Inc.
BEDMINSTER, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies...